These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7908043)

  • 1. Albumin microspheres as a drug delivery system for dexamethasone: pharmaceutical and pharmacokinetic aspects.
    Dilova V; Shishkova V
    J Pharm Pharmacol; 1993 Nov; 45(11):987-9. PubMed ID: 7908043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin microsphere as a drug delivery system for dexamethasone: pharmacokinetics in sheep, residue amount in cows and distribution in rats.
    Dilova V; Konakchieva R; Kanchev L; Dilov P
    Boll Chim Farm; 1999 Oct; 138(9):465-70. PubMed ID: 10682405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
    Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
    Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravitreally injectable poly (D, L-Lactide) microspheres containing dexamethasone acetate for sustained release].
    Wu W; Yang X; Lu B
    Yao Xue Xue Bao; 2001 Oct; 36(10):766-70. PubMed ID: 12579978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone.
    Pavanetto F; Genta I; Giunchedi P; Conti B; Conte U
    J Microencapsul; 1994; 11(4):445-54. PubMed ID: 7931944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres.
    Dräger C; Benziger D; Gao F; Berde CB
    Anesthesiology; 1998 Oct; 89(4):969-79. PubMed ID: 9778015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation.
    Ranjan OP; Shavi GV; Nayak UY; Arumugam K; Averineni RK; Meka SR; Sureshwar P
    Arch Pharm Res; 2011 Nov; 34(11):1919-29. PubMed ID: 22139691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic release of protein from polyethylene glycol and polyethylene glycol/modified dextran microspheres.
    Nguyen HX; O'Rear EA
    J Biomed Mater Res A; 2013 Sep; 101(9):2699-705. PubMed ID: 23427111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of arsenic trioxide albumin microspheres and its release characteristics in vitro.
    Zhou J; Zeng F; Xiang G; Xie S; Wei S
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):310-2, 319. PubMed ID: 16201281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
    Hickey T; Kreutzer D; Burgess DJ; Moussy F
    J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical crosslinked albumin microspheres as potential drug delivery systems: preparation and in vitro studies.
    Iemma F; Spizzirri UG; Puoci F; Muzzalupo R; Trombino S; Picci N
    Drug Deliv; 2005; 12(3):179-84. PubMed ID: 16025848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
    Thote AJ; Gupta RB
    Dis Mon; 2005 Jun; 51(6):362-73. PubMed ID: 16242521
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug release from PLGA microspheres attached to solids using supercritical CO₂.
    Mulia K; Witkamp GJ; Dawes GJ; Fratila-Apachitei LE; Apachitei I; Duszczyk J; Pellikaan H
    J Biomater Appl; 2011 Jan; 25(5):401-12. PubMed ID: 20042430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
    Wells LA; Sheardown H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release.
    Rubino OP; Kowalsky R; Swarbrick J
    Pharm Res; 1993 Jul; 10(7):1059-65. PubMed ID: 8378248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer-by-layer nanoassembly.
    Pargaonkar N; Lvov YM; Li N; Steenekamp JH; de Villiers MM
    Pharm Res; 2005 May; 22(5):826-35. PubMed ID: 15906179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends.
    Rodríguez Villanueva J; Rodríguez Villanueva L; Guzmán Navarro M
    Int J Pharm; 2017 Jan; 516(1-2):342-351. PubMed ID: 27889587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of Pingyangmycin-loaded bovine serum albumin microspheres for embolization therapy.
    Wang C; Liu J; Gao Q; Bi Y; Gan L; Wang X; Hou S
    Int J Pharm; 2007 May; 336(2):361-6. PubMed ID: 17360133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular absorption and biodistribution of dexamethasone from non-aqueous emulsions in the rat.
    Suitthimeathegorn O; Turton JA; Mizuuchi H; Florence AT
    Int J Pharm; 2007 Mar; 331(2):204-10. PubMed ID: 17250983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats.
    Ge YB; Chen DW; Xie LP; Zhang RQ
    Int J Pharm; 2007 Jun; 338(1-2):142-51. PubMed ID: 17363201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.